Skip to main content
. 2023 May 31;15(5):262–267. doi: 10.14740/jocmr4920

Table 2. Percentage of Detected Bacteria in Patients With CD and UC.

Detection bacteriaa CD (n = 68) (%) UC (n = 27) (%) P-valueb
Gram-positive bacteria 29 (42.6) 9 (33.3) 0.489
  Gram-positive streptococcus 28 (41.2) 8 (29.6) 0.353
    Enterococcus sp. 2 (2.9) 1 (3.7) 1
    Staphylococcus spp. 23 (33.8) 7 (10.3) 0.625
      Staphylococcus aureus 3 (4.4) 0 0.556
      MRSA 1 (1.5) 2 (7.4) 0.194
      Staphylococcus epidermidis 16 (23.5) 5 (18.52) 0.785
      CNS 3 (4.4) 0 0.556
    Streptococcus sp. 3 (4.4) 0 0.556
  Gram-positive bacillus 1 (1.5) 1 (3.7) 0.490
    Clostridium subterminale 1 (1.5) 0 1
    Propionibacterium acnes 0 1 (3.7) 0.284
Gram-negative bacteria 24 (35.3) 17 (63.0) 0.021
  Acinetobacter sp. 3 (4.4) 0 0.556
  Corynebacterium sp. 0 1 (3.7) 0.284
  Citrobacter sp. 2 (2.9) 1 (3.7) 1
  Cronobacter sakazakii 0 1 (3.7) 0.284
  Enterobacter sp. 8 (11.8) 3 (11.1) 1
  Escherichia coli 7 (10.3) 2 (7.4) 1
  Fusobacterium nucleatum 0 1 (3.7) 0.284
  Klebsiella pneumoniae 0 3 (11.1) 0.021
  Neisseria sp. 1 (1.5) 0 1
  Pseudomonas aeruginosa 2 (2.9) 5 (18.5) 0.019
  Stenotrophomonas maltophilia 1 (1.5) 0 1
Enterobacteriology bacteria 26 (38.2) 10 (37.0) 1
Anaerritic bacteria 3 (4.4) 0 0.556
Fungus 3 (4.4) 1 (3.7) 1
The strain is unknown 9 (13.2) 0

aMulti-fungus detection. bFisher’s exact test. CD: Crohn’s disease; CNS: coagulase-negative staphylococci; MRSA: methicillin-resistant Staphylococcus aureus; UC: ulcerative colitis.